Leukotriene receptor antagonists--a novel therapeutic approach in atopic dermatitis?
Cysteinyl leukotrienes have been shown to be important in the pathogenesis of both asthma and rhinitis. Improvement of skin manifestations in atopic dermatitis has been reported with leukotriene receptor antagonists. This article reviews current data on the experimental evidence and clinical efficacy of leukotriene receptor antagonists in the treatment of atopic dermatitis.
Kägi
M K
MK
Private Praxis for Dermatology, Allergy and Clinical Immunology, Zürich, Switzerland. praxis.kaegi@hin.ch
D000085:Acetates / Q000627:therapeutic use; D003521:Cyclopropanes; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D015289:Leukotrienes / Q000276:immunology*; D011804:Quinolines / Q000627:therapeutic use; D013440:Sulfides; D014581:Urticaria / Q000276:immunology / Q000503:physiopathology
D000085:Acetates; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D015289:Leukotrienes; D011804:Quinolines; D013440:Sulfides; C093875:montelukast